Monitoring and Safety Considerations Regular monitoring helps ensure safe and effective use of 5-amino-1MQ: Recommended Monitoring: Body weight and measurements (weekly) Energy levels and sleep quality (daily) Injection site assessment (each injection) Overall well-being and any unusual symptoms When to Seek Medical Attention: Persistent or severe side effects Unusual symptoms not resolving within 1-2 weeks Signs of allergic reaction (rash, difficulty breathing) Significant changes in heart rate or blood pressure Unexplained fatigue or weakness Long-Term Safety Considerations While short-term safety data for 5-amino-1MQ appears favorable, long-term safety in humans requires further study

This sets the stage for a future controlled human trial. Reference: Vitamin B12 Supports Skeletal Muscle Oxidative Phosphorylation Capacity in Male Mice by Luisa F Castillo, Katarina E Heyden, Abigail R Williamson, Wenxia Ma, Olga V Malysheva, Nathaniel M Vacanti, Anna E Thalacker-Mercer and Martha S Field, 20 January 2026, The Journal of Nutrition
Keep the EGRIFTA WR TM vials out of the light
It is not intended to treat or diagnose any condition, and is not for human consumption
Diet, microbiome and symptom context: Diet and microbiome factors can be relevant in selected patients, but they should be considered alongside clinical assessment rather than used as a replacement for evidence based IBD care
Can BPC-157 treat pain from my injury